Previous 10 | Next 10 |
Johnson & Johnson beat analysts' estimates for sales and EPS, but lowered its guidance for the year. The strengthening of the dollar has hit Johnson & Johnson hard. Although Johnson & Johnson is not strongly undervalued, its dividend and stability may attract some inve...
Massive short interest buildup is like tinder for a bullish fire. Good economic news is the match for the short-covering rally. Healthcare stocks look especially good and should outperform. After several tortuous weeks of abnormal volatility and a directionless trading e...
As companies adjust to inflation, rising interest rates, and a likely economic slowdown, investors are struggling to compute future earnings and the impact on stock valuations. Broadening the sources of stability can help diversify risk and return potential. Geopolitical risk and ...
Why the economy, practically speaking, may already be in recession. Why defensive sectors may be worth a closer look in the current environment. Market sentiment might be bearish, but that doesn't mean there aren't opportunities. Aggressive moves by central banks...
The first five months of the year marked the worst start for the S&P 500 since 1970 ― and the sixth worst back to 1928. Stock valuations have come down, but company earnings remain solid. Earnings will slow, but 20% is hard to imagine, even in a recession. For fur...
The latest U.S. stock market bounce is underway. How much further and longer can we reasonably expect for it to last. Staying in control as the bear market continues to take hold. For further details see: Two-And-A-Half Weeks Before Topping Out
The latest headline inflation numbers were unequivocally negative. A closer look at a variety of inflation readings including some under the surface of Friday's CPI report provides encouragement. Even if inflation cools in the months ahead, central bankers are likely to remain agg...
iShares U.S. Pharmaceuticals ETF (IHE) - $0.7171. 30-Day SEC Yield of 1.63% as of April. 29. Payable Jun 15; for shareholders of record Jun 10; ex-div Jun 09. For further details see: iShares U.S. Pharmaceuticals ETF declares quarterly distribution of $0.7171
How similar will the next three or five years look from the years that immediately preceded the pandemic? And what are the implications for us as global equity investors? We don’t expect anything like the hyperinflation and stagflation we experienced in the 1970s; our outlook s...
Today's stock bear market has only just begun. No relief in sight. Elevate your stock investment strategy to find opportunities that remain abundant within the broader market. For further details see: We've Only Just Begun
News, Short Squeeze, Breakout and More Instantly...
iShares U.S. Pharmaceutical Company Name:
IHE Stock Symbol:
NYSE Market:
2024-07-12 08:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-22 11:22:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-05-31 20:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...